Play Live Radio
Next Up:
0:00
0:00
0:00 0:00
Available On Air Stations

Johnson & Johnson Applies For Emergency Use Authorization For COVID-19 Vaccine

The company's vaccine has shown to be 85% effective against severe forms of the disease. Patients will only need to receive one shot instead of two, as with other vaccines already in use in the U.S.

Copyright 2021 NPR

Dustin Jones is a reporter for NPR's digital news desk. He mainly covers breaking news, but enjoys working on long-form narrative pieces.